Wrapping Up 2017 – some noteworthy medicines law and policy events.
2017 was a significant year for access to medicines and other medicines policy related events. Here are a few highlights of the last 12...
Ellen ‘t Hoen named one of the “50 Most Influential People in IP”
For Ellen ‘t Hoen's "fierce" advocacy on access to medicine, and in particular for her efforts under the Covid-19 pandemic to ensure knowledge and...
Intervention at Intergovernmental Negotiating Body to draft and negotiate a WHO convention, agreement or...
The following intervention was delivered by Ellen 't Hoen on 18 March, 2024
Download this statement as a PDF here.
Thank you for the opportunity to...
Strong call for transparency on medicine prices, cost of R&D at WHO Fair Pricing...
“Medical innovation has little social value if most people cannot access its benefits…. this is a global human rights issue,” said Mariângela Simão, Assistant...
Wrapping up 2021 – some noteworthy medicines law and policy events
Welcome to the annual end of the year blog, our highly biased overview of noteworthy events in the field of medicines law and policy....
Pandemic treaty must ensure timely access to technology and know-how
This statement was delivered by Medicines Law & Policy at the Intergovernmental Negotiating Body (INB), Session 12 (resumed), 4 December 2024
Thank you, co-chairs. We...
Covid-19 intellectual property pool gaining support
While drug and vaccine developers are working on tools to prevent and treat Covid- 19, here is a question the rest of us should...
ML&P’s Statement at the Intergovernmental Negotiating Body on a pandemic accord
This statement was delivered by Kaitlin Mara at the World Health Organization's seventh meeting and drafting group of the Intergovernmental Negotiating Body (INB) to...
WHO Members meet to finalise the Pathogen Access and Benefit Sharing Instrument
In May 2025, the WHO member states adopted the Pandemic Agreement, but they left the work to establish an instrument for Pathogen Access and...
European Commission Publishes Expert Panel’s Recommendations on High Drug Prices
This month the European Commission published Innovative Payment Models for High-Cost Innovative Medicines, a report of the Expert Panel on effective ways of investing...